Escherichia coli 83972 Bacteriuria Protects Against Recurrent Lower Urinary Tract Infections in Patients With Incomplete Bladder Emptying

Kunin, 1997

BMJ, 2008, Risks of extended-spectrum beta-lactamases, Drug Ther Bull, 46, 21, 10.1136/dtb.2008.03.0006

Goossens, 2005, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, Lancet, 365, 579, 10.1016/S0140-6736(05)70799-6

Grabe

Drekonja, 2008, Urinary tract infections, Prim Care, 35, 345, 10.1016/j.pop.2008.01.001

Nicolle, 2005, Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults, Clin Infect Dis, 40, 643, 10.1086/427507

Hansson, 1989, Untreated asymptomatic bacteriuria in girls: II–Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections, BMJ, 298, 856, 10.1136/bmj.298.6677.856

Reid, 2001, Can bacterial interference prevent infection?, Trends Microbiol, 9, 424, 10.1016/S0966-842X(01)02132-1

Andersson, 1991, Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence, Infect Immun, 59, 2915, 10.1128/IAI.59.9.2915-2921.1991

Wullt, 1998, Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases, J Urol, 159, 2057, 10.1016/S0022-5347(01)63246-4

Lindberg, 1975, Asymptomatic bacteriuria in school girls, Acta Paediatr Scand, 64, 718, 10.1111/j.1651-2227.1975.tb03910.x

Hull, 1999, Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria, Infect Immun, 67, 429, 10.1128/IAI.67.1.429-432.1999

Hull, 2000, Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients, J Urol, 163, 872, 10.1016/S0022-5347(05)67823-8

Sunden, 2006, Bacterial interference–is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?, Int J Antimicrob Agents, 28, S26, 10.1016/j.ijantimicag.2006.05.007

Gupta, 2001, Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women, Ann Intern Med, 135, 9, 10.7326/0003-4819-135-1-200107030-00004

Wullt, 2003, The host response to urinary tract infection, Infect Dis Clin North Am, 17, 279, 10.1016/S0891-5520(03)00028-X

Darouiche, 2005, Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial, Clin Infect Dis, 41, 1531, 10.1086/497272

Ragnarsdottir, 2008, TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections, Eur J Clin Invest, 38, 12, 10.1111/j.1365-2362.2008.02004.x

Klemm, 2006, Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen, Infect Immun, 74, 781, 10.1128/IAI.74.1.781-785.2006

Zdziarski, 2008, Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?, Infect Immun, 76, 695, 10.1128/IAI.01215-07

Bergsten, 2004, PapG-dependent adherence breaks mucosal inertia and triggers the innate host response, J Infect Dis, 189, 1734, 10.1086/383278

Bergsten, 2007, Do type 1 fimbriae promote inflammation in the human urinary tract?, Cell Microbiol, 9, 1766, 10.1111/j.1462-5822.2007.00912.x